New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics ...

Rhythm Biosciences has materially improved the predictive accuracy of its geneType colorectal cancer risk assessment clinical ...

Saga Diagnostics expanded the use of its ultrasensitive blood test to include detection of tiny amounts of colorectal cancer ...

Active-duty service members and eligible family members in Alaska now have access to blood test for colorectal cancer screening with no copay.

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

In about 5–10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

By Cheryl Harewood Barbados has one of the highest incidences of colorectal cancer globally and according to the Pan American ...

For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...

Mariana Tata experienced a few subtle, common symptoms of colon cancer and got them checked out. She was diagnosed at stage 4 ...

In about 5–10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.